Merit Medical Systems Investing Activities - Other 2010-2025 | MMSI
Merit Medical Systems annual/quarterly investing activities - other history and growth rate from 2010 to 2025. Investing activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the investing activities section of the Cash Flows Statement
- Merit Medical Systems investing activities - other for the quarter ending March 31, 2025 was $-0.007B, a 9.36% increase year-over-year.
- Merit Medical Systems investing activities - other for the twelve months ending March 31, 2025 was $-0.030B, a 169.68% increase year-over-year.
- Merit Medical Systems annual investing activities - other for 2024 was $-0.01B, a 119.41% increase from 2023.
- Merit Medical Systems annual investing activities - other for 2023 was $-0.005B, a 236.76% increase from 2022.
- Merit Medical Systems annual investing activities - other for 2022 was $-0.001B, a 455.91% increase from 2021.
Merit Medical Systems Annual Investing Activities - Other
(Millions of US $) |
| 2024 |
$-10 |
| 2023 |
$-5 |
| 2022 |
$-1 |
| 2021 |
$0 |
| 2020 |
$0 |
| 2019 |
$N/A |
| 2018 |
$-11 |
| 2017 |
$N/A |
| 2016 |
$N/A |
| 2015 |
$2 |
| 2014 |
$6 |
| 2013 |
$24 |
| 2012 |
$N/A |
| 2011 |
$N/A |
| 2010 |
$N/A |
| 2009 |
$N/A |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$5.703B |
$1.357B |
|
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|
